CONSIDERATIONS TO KNOW ABOUT AZELAPRAG SMALL MOLECULE

- "Tolvaptan is approved for ADPKD therapy, but its use is limited by numerous adverse outcomes, leaving an unmet clinical will need for Protected and efficient therapy.Strong cytochrome P450 3A4 and/or P-glycoprotein inhibitors could warrant AMG 986 dose reduction and will be coadministered with warning in sufferers with heart failure addressed wi